More on Quest Diagnostics Q1 results

• Q1 revenues: $1.75B (-2.3%).
• Income from continuing operations: $104M (-10.3%).
• EPS: $0.71 (-0.1%).
• Value per requisition decreased 2.8% due to changes in reimbursement and last year's toxicology acquisition.
• Harsh winter weather decreased revenues and volume by 2% and adjusted EPS by $0.11.
• CF Ops: $84M (+$78.7%).
• 2014 guidance:
• Revenue growth: 2% - 4%.
• Adjusted EPS: $3.95 - $4.15.
• CF Ops: $300M.
• CAPEX: $300M.
• (DGX -2%)